The global market for connected insulin pens could be worth up to $123 million by 2023, according to a report published this year by Research & Markets.
Insulin pens, designed for people who control their diabetes with multiple daily injections instead of a pump or wearable patch, are portable devices that were first introduced in 1985 with Novo Nordisk‘s (NYSE:NVO) NovoPen. Since then, technology has evolved to allow users to track their insulin usage, set reminders and alarms, as well as share their data with caregivers and doctors. Here’s a look at some of the key players shaping the future of connected insulin pens.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.